LCP Tacro (tacrolimus)

DRUG2 trials

Sponsors

Veloxis Pharmaceuticals, Chiesi Poland Sp. z o.o.

Conditions

Kidney TransplantRenal Failure

Phase 2

Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

CompletedNCT00496483

Veloxis PharmaceuticalsRenal Failure

Start: 2007-07-31End: 2008-03-31Updated: 2015-07-23

Unknown Phase

Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients

RecruitingNCT06833463

Chiesi Poland Sp. z o.o.Kidney Transplant

Start: 2025-05-29End: 2028-01-30Target: 120Updated: 2026-04-02